These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 8943789)
1. Regulation of aromatase and sulphatase in breast tumour cells. Purohit A; Wang DY; Ghilchik MW; Reed MJ J Endocrinol; 1996 Sep; 150 Suppl():S65-71. PubMed ID: 8943789 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor necrosis factor alpha-stimulated aromatase activity by microtubule-stabilizing agents, paclitaxel and 2-methoxyestradiol. Purohit A; Singh A; Ghilchik MW; Reed MJ Biochem Biophys Res Commun; 1999 Jul; 261(1):214-7. PubMed ID: 10405348 [TBL] [Abstract][Full Text] [Related]
3. Control of aromatase activity in breast tumours: the role of the immune system. Singh A; Purohit A; Duncan LJ; Mokbel K; Ghilchik MW; Reed MJ J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):185-92. PubMed ID: 9365189 [TBL] [Abstract][Full Text] [Related]
4. Regulation of aromatase activity by cytokines, PGE2 and 2-methoxyoestrone-3-O-sulphamate in fibroblasts derived from normal and malignant breast tissues. Purohit A; Ghilchik MW; Leese MP; Potter BV; Reed MJ J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):167-72. PubMed ID: 15862962 [TBL] [Abstract][Full Text] [Related]
5. Oestrone sulphatase activity in normal and malignant breast tissues: relationship with tumour location. Chapman O; Purohit A; Wang DY; Ghilchik MW; Reed MJ Anticancer Res; 1995; 15(4):1467-71. PubMed ID: 7654035 [TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma ligands inhibit estrogen biosynthesis in human breast adipose tissue: possible implications for breast cancer therapy. Rubin GL; Zhao Y; Kalus AM; Simpson ER Cancer Res; 2000 Mar; 60(6):1604-8. PubMed ID: 10749129 [TBL] [Abstract][Full Text] [Related]
7. The role of cytokines and sulphatase inhibitors in regulating oestrogen synthesis in breast tumours. Reed MJ; Purohit A; Duncan LJ; Singh A; Roberts CJ; Williams GJ; Potter BV J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):413-20. PubMed ID: 7626490 [TBL] [Abstract][Full Text] [Related]
8. Control and expression of oestrone sulphatase activities in human breast cancer. Pasqualini JR; Chetrite G; Nestour EL J Endocrinol; 1996 Sep; 150 Suppl():S99-105. PubMed ID: 8943793 [TBL] [Abstract][Full Text] [Related]
9. Steroid and growth factor modulation of aromatase activity in MCF7 and T47D breast carcinoma cell lines. Ryde CM; Nicholls JE; Dowsett M Cancer Res; 1992 Mar; 52(6):1411-5. PubMed ID: 1311630 [TBL] [Abstract][Full Text] [Related]
10. Determinants of tissue oestradiol levels in human breast cancer. Santen RJ Cancer Surv; 1986; 5(3):597-616. PubMed ID: 3555785 [TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction. Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794 [TBL] [Abstract][Full Text] [Related]
12. IL-6sR: release from MCF-7 breast cancer cells and role in regulating peripheral oestrogen synthesis. Singh A; Purohit A; Wang DY; Duncan LJ; Ghilchik MW; Reed MJ J Endocrinol; 1995 Nov; 147(2):R9-12. PubMed ID: 7490545 [TBL] [Abstract][Full Text] [Related]
13. Oestrogen formation in breast: clinical and biological importance. Dowsett M; Detre S; Rowlands M; Grimshaw R J Endocrinol; 1996 Sep; 150 Suppl():S59-63. PubMed ID: 8943788 [TBL] [Abstract][Full Text] [Related]
14. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells. Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907 [TBL] [Abstract][Full Text] [Related]
15. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer. Miller WR; Stuart M; Sahmoud T; Dixon JM Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282 [TBL] [Abstract][Full Text] [Related]
16. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene. Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000 [TBL] [Abstract][Full Text] [Related]
17. 4- and 6-(p-Sulphamoylphenyl)androstenediones: Studies of aromatase inhibitor-based oestrone sulphatase inhibition. Watari Y; Yamaguchi S; Takahashi M; Nagaoka M; Numazawa M Steroids; 2010 Dec; 75(12):891-6. PubMed ID: 20546769 [TBL] [Abstract][Full Text] [Related]
18. The regulation and inhibition of 17beta-hydroxysteroid dehydrogenase in breast cancer. Purohit A; Tutill HJ; Day JM; Chander SK; Lawrence HR; Allan GM; Fischer DS; Vicker N; Newman SP; Potter BV; Reed MJ Mol Cell Endocrinol; 2006 Mar; 248(1-2):199-203. PubMed ID: 16414180 [TBL] [Abstract][Full Text] [Related]
19. In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients. Licznerska BE; Wegman PP; Nordenskjöld B; Wingren S Breast Cancer Res Treat; 2008 Nov; 112(1):15-23. PubMed ID: 18030614 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of oestrone sulphatase activity in the MDA-MB-231 breast cancer cell line by breast cyst fluid from Malaysian women. Elsadig RE; Reimann K; Yip CH; Lai LC Anticancer Res; 2001; 21(4A):2693-6. PubMed ID: 11724341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]